Foghorn Therapeutics Inc.

FHTX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001822462

SEC filings (opens in a new tab)

No open-market purchases or sales by Foghorn Therapeutics Inc. insiders were filed in the last 90 days; 102 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Foghorn Therapeutics Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of FHTX: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Q3 2023	Change
Holders	59	61	+2
Shares	26.8M	26.9M	+161.2K (+0.6%)
Value	$188.4M	$134.6M	−$53.8M (−28.5%)

New holders (3)

Institutions that held Foghorn Therapeutics Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to FHTX in Q3 2023
Institution	Shares	Value	% of portfolio
Panagora Asset Management Inc	34,576	$172.9K	0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)	2,512	$12.6K	0.00%
TFC Financial Management	123	$615	0.00%

Sold out (1)

Institutions that held Foghorn Therapeutics Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of FHTX in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
State Board of Administration of Florida Retirement System	12,464	$87.7K